Page 6 - Bioreference Health News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bioreference health. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bioreference Health Today - Breaking & Trending Today

BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing

ELMWOOD PARK, N.J., Nov. 28, 2023 /PRNewswire/ BioReference® Health, LLC (BRH), a leading specialty laboratory in the United States, announced . ....

United States , New Jersey , Elmwood Park , Emily Smith , Prnewswire Bioreference , Anuj Kalsy , Ashley Triscuit , Bioreference Health , Health Inc , Prognos Health , Arrangements At Bioreference Health , Pharmaceutical Arrangements , Sundeep Bhan , Reference Health ,

Opko Health (OPK) Q3 2023 Earnings Call Transcript

OPK earnings call for the period ending September 30, 2023. ....

United Kingdom , United States , Hong Kong , Dipesh Patel , Yale Jen Laidlaw , Maury Raycroft Jefferies , Phillip Frost , Jeffrey Cohen , Ted Tenthoff Piper Sandler , Yale Jen , Elias Zerhouni , Edward Tenthoff , Yi Chen , Charlie Bishop , Maury Raycroft , Jeffrey Cohen Ladenburg Thalmann , Lyvonne Briggs , Charles Bishop , Bioreference Health , Department Of Health , Development Authority , Company Analyst , American Urology Association , Ladenburg Thalmann , Renal Division , Centera Bio ,

BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™

/PRNewswire/ SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that BioReference®. ....

Elmwood Park , New Jersey , United States , Ellen Beausang , Memorial Sloan Kettering Cancer Center , Health Inc , Bioreference Health , Philippe Menu , Chief Medical Officer , Chief Product Officer , Genpath Oncology , Chief Commercial Officer , Sophia Genetics ,

OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results

Conference call begins at 4:30 p.m. Eastern time todayMIAMI, Nov. 06, 2023 (GLOBE NEWSWIRE) OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and nine months ended September 30, 2023. Business highlights from the third quarter and subsequent weeks included the following: ModeX Therapeutics Inc. (ModeX) was awarded a contract from the Biomedical Advanced Research and Development Authority (BARDA) to develop novel multispecific antibodies against vi ....

United Arab Emirates , United Kingdom , United States , Bruce Voss , Lyvonne Briggs , Development Authority , Bioreference Health , Biomedical Advanced Research , Modex Therapeutics Inc , Exchange Commission , Health Inc , Entera Bio Ltd , American Society Of Nephrology Kidney Week , Kidney Week , American Society , Nephrology Kidney , Centera Bio , Reference Health , Private Securities Litigation Reform Act , Annual Reports , Consolidated Statements , Opko Health , Gross Profit , Iral Infectious Disease , Clinical Trial , Clinical Data ,

OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results

MIAMI, Nov. 06, 2023 (GLOBE NEWSWIRE) OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and nin. ....

United States , United Arab Emirates , United Kingdom , Bruce Voss , Lyvonne Briggs , Health Inc , Exchange Commission , Biomedical Advanced Research , Bioreference Health , Entera Bio Ltd , American Society Of Nephrology Kidney Week , Modex Therapeutics Inc , Development Authority , Kidney Week , American Society , Nephrology Kidney , Centera Bio , Reference Health , Private Securities Litigation Reform Act , Annual Reports , Consolidated Statements ,